HealthAmgen says Sjogren’s drug cuts disease activity in trial
Amgen said on Wednesday that detailed data from a late-stage trial showed its experimental Sjogren’s disease drug significantly reduced disease activity in patients.
Amgen says Sjogren’s drug cuts disease activity in trial
